News
12-Month Net Sales Reached ~$19.7 million, Gain of ~31% for FY2024 ended Feb 29, 2024

8 April 2024

News
Pittsburgh, PA, April 03, 2024 - PrismMediaWire - Lipella Pharmaceuticals Inc., (Nasdaq: LIPO) ("Lipella," "our," "us" or the "Company"), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announces that its abstract has...

5 April 2024

News
SKYX Enhances its Robust Patent Portfolio Which Now Totals over 90 Issued and Pending Patents with over 30 Issued Patents

4 April 2024

News
Pittsburgh, PA, April 03, 2024 - Lipella Pharmaceuticals Inc., (Nasdaq: LIPO) ("Lipella," "our," "us" or the "Company"), a clinical-stage biotechnology company addressing serious diseases with significant unmet need, today announced that the U.S. Food and Drug Administra...

3 April 2024

News
Dr. Lawal has Deep Renewable Energy Expertise in Chemical Energy Conversion Processes

3 April 2024

News
HAUPPAUGE, April 02, 2024 - PRISM MediaWire - AmpliTech Group, Inc (Nasdaq: AMPG), a designer, developer, and manufacturer of state-of-the-art signal-processing components for satellite, 5G, other communications networks, design of complete 5G/6G systems, global distribu...

2 April 2024

News
Revenue Continues to Accelerate, Increasing 53% in First Half of FY2024

2 April 2024

News
2023 net revenue of $2.83M, up 276% versus prioryear due to major retailer engagements

2 April 2024

News
Acquisition of Evtec Progressing Toward Closing

1 April 2024

News
SKYX reports $22.4 million in cash, cash equivalents, restricted cash, available cash, and investments available for sale as of December 31, 2023, as compared to $16.8 million as of December 31, 2022

1 April 2024

7
8
9
10
11
12
13
We use cookies to run our website, analyze your use of our services, manage your online preference & personalize ad content. By accepting our cookies, you’ll get relevant content and social media features, personalized ads, and an enhanced browsing experience. To manage your choices, click „Cookie Settings”. Necessary cookies are required for the core website functionality and cannot be rejected. For more information, see our Cookie Policy.
Cookie settings
Cookies used on the site are categorized and below you can read about each category and allow or deny some or all of them, except for Necessary Cookies which are required to provide core website functionality. When categories that have been previously allowed are disabled, all cookies assigned to that category will be removed from your browser. You can see a list of cookies assigned to each category and detailed information on those cookies in the “Cookie Policy” tab.
Necessary cookies
Some cookies are required to provide core functionality. The website won't function properly without these cookies and they are enabled by default and cannot be disabled.
Preferences
Preference cookies enables the website to remember information to customize how the website looks or behaves for each user. This may include storing selected currency region, language or color theme.
Analytical cookies
Analytical cookies help us improve our website by collecting and reporting information on its usage.
Marketing cookies
Marketing cookies are used to track visitors across websites to allow publishers to display relevant and engaging advertisements. By enabling marketing cookies, you grant permission for personalized advertising across various platforms.